Scrip Asks…What Does 2020 Hold For Biopharma? Part 1: Therapeutic Advances
R&D Boom Drives Industry Transformation
Advances in multiple scientific areas will mature into novel therapeutics, often tailored for the individual patient and increasingly curative, making biopharma an exciting place to be in 2020.
